A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Clinical trial NCT07446439 · RECRUITING

Trial details

NCT number: NCT07446439
Sponsor: Vanda Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea and Vomiting Obesity

Start date: 2026-03-27
Primary completion: 2026-12-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.